Download PDF
Thromb Haemost 2006; 96(01): 100-101
DOI: 10.1160/TH05-12-0827
Letters to the Editor
Schattauer GmbH

Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients

Ya Ping Wu   *
1   Department of Medicine, Taishan Medical University, Tai-an, China
2   Department of Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
,
Ran Wei   *
1   Department of Medicine, Taishan Medical University, Tai-an, China
,
Zhong Hua Liu   *
3   National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
,
Biao Chen
4   Department of Medicine, Xuanwu Hospital of Capital University of Medical Sciences, Beijing, China
,
Ton Lisman
2   Department of Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
,
Dao Ling Ren
1   Department of Medicine, Taishan Medical University, Tai-an, China
,
Ji Ju Han
1   Department of Medicine, Taishan Medical University, Tai-an, China
,
Zuo Li Xia
1   Department of Medicine, Taishan Medical University, Tai-an, China
,
Fu Sheng Zhang
5   Department of Medicine, Taian Medical Center, Tai-an, China
,
Wen Bo Xu
3   National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
,
Klaus T. Preissner
6   Institute for Biochemistry, Medical Faculty, Justus Liebig University, Giessen, Germany
,
Philip G. de Groot
2   Department of Haematology, University Medical Center Utrecht, Utrecht, The Netherlands
› Author AffiliationsFinancial support: This study was supported in part by The Dutch Thrombosis Foundation (grant 20023), Natural Science Foundation of Shandong (grant Y2003C01) and National Natural Science Foundation of China (NSFC grant 30300395).
Further Information

Publication History

Received 28 December 2005

Accepted after resubmission 17 May 2006

Publication Date:
29 November 2017 (online)

    Permissions and Reprints

 

* These authors contributed equally.


 

  • References

  • 1 Ng KH. et al. Pulmonary artery thrombosis ina patient with severe acute respiratory syndrome. Postgrad Med J 2005; 81: e3.
    CrossrefPubMedGoogle Scholar
  • 2 Wu YP. et al. SARS in Hong Kong. N Engl J Med 2003; 349: 708-9.
    CrossrefPubMedGoogle Scholar
  • 3 Lang ZW. et al. A clinicopathological study of three cases of SARS. Pathology 2003; 35: 526-31.
    CrossrefPubMedGoogle Scholar
  • 4 Rezaie AR. Vitronectin functions as a cofactor for rapid inhibition of activated proteinC by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C. J Biol Chem 2001; 276: 15567-70.
    CrossrefPubMedGoogle Scholar
  • 5 World Health Organization (WHO). Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003; 78: 81-3.
    PubMedGoogle Scholar
  • 6 Muller MP. et al. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?. Clin Infect Dis 2005; 40: 1079-86.
    CrossrefPubMedGoogle Scholar
  • 7 Greiner M. Two-graph receiver operating characteristic (TG-ROC): update version supports optimisation of cut-off values that minimise overall misclassification costs. J Immunol Methods 1996; 191: 93-4.
    CrossrefPubMedGoogle Scholar
  • 8 CMDT Users Manual. Institute for Parasitology and Tropical Veterinary Medicine. Freie Universität; Berlin, Germany: Available by e-mail: cmdt@gmx.net.
    Google Scholar
  • 9 Henderson AR. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem 1993; 30: 521-39.
    CrossrefPubMedGoogle Scholar
  • 10 Tang BS. et al. Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by SARScoronavirus and human coronavirus 229E. J Virol 2005; 79: 6180-93.
    CrossrefPubMedGoogle Scholar
  • 11 Wada H. et al. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am J Hematol 2003; 72: 1-7.
    CrossrefPubMedGoogle Scholar
  • 12 Lijnen HR. Pleiotropic functions of plasminogen activator inhibitor-1. J Thromb Haemost 2005; 03: 35-45.
    CrossrefPubMedGoogle Scholar
  • 13 Chavakis T. et al. Inhibition of platelet adhesion and aggregation bya defined region (Gly-486-Lys-502) of high molecular weight kininogen. J Biol Chem 2002; 26: 23157-64.
    PubMedGoogle Scholar
  • 14 Reheman A. et al. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost 2005; 03: 875-83.
    CrossrefPubMedGoogle Scholar
  • 15 Wu YP. et al. Fibrin-incorporated vitronectin is involved in platelet adhesion and thrombus formation through homotypic interactions with platelet-associated vitronectin. Blood 2004; 104: 1034-41.
    CrossrefPubMedGoogle Scholar